Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma

Utthara Nayar; Pin Lu; Jelena Vider; Leandro Cerchietti; Gabriela Chiosis; Lynn Wang; Ronald Blasberg; Ethel Cesarman

首页> 外文期刊>Infectious Agents and Cancer >Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma

【24h】

Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma

机译：Hsp90是治疗KSHV相关原发渗出性淋巴瘤的可行治疗靶标

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Infectious Agents and Cancer》 |2010年第s1期|共页
作者
Utthara Nayar; Pin Lu; Jelena Vider; Leandro Cerchietti; Gabriela Chiosis; Lynn Wang; Ronald Blasberg; Ethel Cesarman;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP k13-induced NF-κB [J] . GopalakrishnanR., MattaH., ChaudharyP.M. Clinical cancer research: an official journal of the American Association for Cancer Research . 2013,第18期

机译：嘌呤支架HSP90抑制剂BIIB021对KSHV相关原发性淋巴瘤具有选择性活性，并阻断vFLIP k13诱导的NF-κB
2. Targeting Sphingosine Kinase Induces Apoptosis and Tumor Regression for KSHV-Associated Primary Effusion Lymphoma [J] . Qin Zhiqiang, Dai Lu, Trillo-Tinoco Jimena, Molecular cancer therapeutics . 2014,第1期

机译：靶向鞘氨醇激酶诱导与KSHV相关的原发性淋巴瘤的凋亡和肿瘤消退
3. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors [J] . B Tolani, R Gopalakrishnan, V Punj, Oncogene . 2014,第22期

机译：用BET溴结构域抑制剂靶向KSHV相关原发性淋巴瘤中的Myc
4. Combination Targeting of Immunoliposomal Therapeutics in a Murine Model of B-cell Lymphoma [C] . Annual meeting exposition of the Controlled Release Society . 2009

机译：B细胞淋巴瘤鼠模型中免疫脂质瘤治疗剂的组合靶向
5. Stimuli-responsive targeted therapeutics for treatment of primary and metastatic prostate cancer. [D] . Peng, Zheng-Hong Joseph. 2014

机译：刺激反应性靶向疗法，用于治疗原发性和转移性前列腺癌。
6. Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma [O] . Utthara Nayar, Pin Lu, Jelena Vider, 2010

机译：Hsp90是治疗KSHV相关原发性淋巴瘤的可行治疗靶标
7. Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma [O] . Utthara Nayar, Pin Lu, Jelena Vider, 2010

机译：Hsp90是治疗KSHV相关原发性淋巴瘤的可行治疗靶标
8. Cyclin E1 as a Therapeutic Target in Women with High Grade Serous Ovarian Cancer and Primary Treatment Failure. [R] . Bowtell, D., Beach, J. 2016

机译：Cyclin E1作为高级别浆液性卵巢癌和原发性治疗失败女性的治疗靶点。

Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma

著录项

相似文献

相关主题

期刊订阅